
Genfit S.A.
Genfit S.A. (GNFTF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GNFTF · as of Jun 9, 2026
Key Statistics
Explore Genfit S.A. Data
gnftf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 100.0%
Competitors & Peers
gnftf competitorsStock Performance
Full HistoryAbout Genfit S.A.
Genfit S.A. is a biopharmaceutical company primarily engaged in the discovery and development of innovative therapeutic candidates and diagnostic tools, specifically targeting metabolic and various li…
what is genfit s.a. · gnftf stock overview · genfit s.a. company profile · who is genfit s.a. ceo · gnftf OTC · genfit s.a. headquarters · genfit s.a. business segments
About Stock Overview & Key Data
Genfit S.A. (GNFTF) is a Healthcare company in the Biotechnology industry, listed on OTC since Jan 27, 2014. As of the latest trading session, GNFTF stock price is $9.50, with a market capitalization of $475.8M. The stock has returned +168.36% over the past 12 months and +58.33% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Genfit S.A. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Genfit S.A. reported revenue of $65.4M and net income of -$85.9M. For detailed data — including Genfit S.A. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Genfit S.A. (GNFTF) stock price is $9.50. The stock is traded on OTC under the ticker symbol GNFTF. The 52-week range is $3.28 – $11.05.